Adherex Technologies (FENC)
(Delayed Data from NSDQ)
$8.32 USD
+0.48 (6.12%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $8.35 +0.03 (0.36%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
FENC 8.32 +0.48(6.12%)
Will FENC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FENC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FENC
Are Medical Stocks Lagging Editas Medicine (EDIT) This Year?
Recent Price Trend in Adherex Technologies (FENC) is Your Friend, Here's Why
FENC: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Joint Misses Q1 Earnings Estimates on Rising Expenses
Acadia Healthcare Q1 Earnings Top Estimates on Rising Admissions
Adherex Technologies Inc. (FENC) Reports Q1 Loss, Tops Revenue Estimates
Other News for FENC
Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (FENC)
Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (FENC)
Fennec management to meet with Craig-Hallum
Fennec Pharmaceuticals Approves Proposals at Shareholder Meeting
Fennec Announces Results of Annual Meeting | FENC Stock News